Dyadic International IncDYAI
Price (close)
$0.42
Market cap
$15.3M
P/E
—
Revenue (TTM)
$3.8M
Net income
-$7.6M
Dividend yield
—
1-year total return
-64.1%
Net margin
-200.5%
Revenue growth
-8.0%
Debt / equity
—
What Dyadic International Inc does.
doing business as Dyadic Applied BioSolutions, is a global biotechnology company based in Jupiter, Florida, with operations in the United
States and a satellite office in the Netherlands. The Company develops, manufactures, and commercializes precision-engineered, animal-free
recombinant proteins and enzymes for applications in life sciences, food and nutrition, and bio-industrial markets. These products are
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.6M | $2.4M | $2.9M | $2.9M | $3.5M | $3.1M |
| Net income | -$9.3M | -$13.1M | -$9.7M | -$6.8M | -$5.8M | -$7.4M |
More on DYAI.
- Dyadic International Inc summary
- Dyadic International Inc financial statements
- Dyadic International Inc key metrics
- Dyadic International Inc health scores and style box
- Dyadic International Inc earnings
- Dyadic International Inc dividends
- Dyadic International Inc valuation
- Dyadic International Inc ownership and insiders
- Dyadic International Inc peers
Figures from Dyadic International Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.